Cargando…
Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) is a heterogeneous group of breast cancers characterized by their lack of estrogen receptors, progesterone receptors, and the HER2 receptor. They are more aggressive than other breast cancer subtypes, with a higher mean tumor size, higher tumor grade, the worst f...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452226/ https://www.ncbi.nlm.nih.gov/pubmed/37627272 http://dx.doi.org/10.3390/biom13081207 |